Article
Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.
PloS one - 1 Jan 2012
Dantes Raymund, Metcalfe John, Kim Elizabeth, Kato-Maeda Midori, Hopewell Philip C, Kawamura Masae, Nahid Payam, Cattamanchi Adithya
Abstract excerpt
BACKGROUND: Specific isoniazid (INH) resistance conferring mutations have been shown to impact the likelihood of tuberculosis (TB) transmission. However, their role in the clinical presentation and outcomes of TB has not been evaluated. METHODS: We included all cases of culture-confirmed, INH mon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
